Evaluation of Effective Dose During Abdominal Three-Dimensional Imaging for Three Flat-Panel-Detector Angiography Systems

Abstract

The purpose of this study was to evaluate the effective dose during abdominal three-dimensional (3D) imaging on phantoms and estimate the dose-area product (DAP) for effective dose conversion factors for three types of angiographic units. Three-dimensional imaging was performed for three sizes (small, medium, large) of human-shaped phantoms using three types of angiographic units (Allura Xper FD20/10, INNOVA 4100, AXIOM Artis dTA). We calculated 25 organ doses and effective doses using Monte Carlo technique for the three phantoms with a program for a personal computer. As benchmark studies to back up the results by Monte Carlo technique, we measured the organ doses directly on the small phantom using radiophotoluminescent glass dosimeters. The DAP value increased as the phantom size increased. The organ doses and the effective doses during the 3D imaging increased as the phantom size increased. The effective doses for the small phantom by Monte Carlo technique were 1.9, 2.2, and 2.1 mSv for the Allura Xper FD20/10, INNOVA 4100, and AXIOM Artis dTA, respectively, while those by direct measurement were 1.6, 2.0, and 2.6 mSv. The effective doses to DAP ratios by Monte Carlo technique were 0.37–0.45, 0.26–0.32, and 0.13–0.15 (mSv Gy⁻¹ cm⁻²) for the Allura Xper FD20/10, INNOVA 4100, and AXIOM Artis dTA, respectively. In conclusion, the effective doses during 3D imaging and the dose-to-DAP ratios differ among angiographic units, and the effective dose can be estimated using a proper conversion factor for each angiographic unit.